OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony

Type:

Video

William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.

December 14, 2011 Diabetes and Biotechnology: A Shared History…A Great Future	December 13, 2011 The AquAdvantage Salmon	November 29, 2011 Laurence Marton on Personalized Medicine	November 4, 2011 Breast Cancer and Biotechnology: Bigger Than Pink
November 1, 2011 Repositioning Drugs for Parkinson's Disease	September 29, 2011 Dr. Paul Offit on the Importance of Vaccines and Impediments to Breakthroughs	September 28, 2011 Bernard Siegel of the Genetics Policy Institute Discusses Stem Cell Research	September 27, 2011 Becoming a Part of the Biotech Industry